Kyoto, Japan

Koichi Ushimaru


Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 76(Granted Patents)


Location History:

  • Kyoto, JP (1985 - 1988)
  • Kamikyo, JP (1989)

Company Filing History:


Years Active: 1985-1989

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Koichi Ushimaru: Innovator in Pharmaceutical Compositions

Introduction

Koichi Ushimaru is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. With a total of 5 patents to his name, Ushimaru's work has had a meaningful impact on healthcare.

Latest Patents

Ushimaru's latest patents include groundbreaking formulations. One of his notable inventions is related to Nifedipine compositions, which are designed for administration to humans and animals to effect coronary dilation and achieve a hypotensive effect. Another significant patent involves the stabilization of azulene derivatives, specifically Sodium 1,4-dimethylisopropylazulene-3-sulfonate, which is stabilized by dissolving it in a suitable solvent and subsequently removing the solvent through spray-drying or lyophilization.

Career Highlights

Koichi Ushimaru is currently associated with Nippon Shinyaku Company, Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that enhance patient care and treatment outcomes.

Collaborations

Ushimaru has collaborated with esteemed colleagues, including Masanobu Kawamata and Hiroyuki Goshi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.

Conclusion

Koichi Ushimaru's contributions to pharmaceutical innovations exemplify the importance of research and development in healthcare. His patents reflect a commitment to improving medical treatments and enhancing the quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…